PATENT CLAIM ANALYSIS

Application Number: 15973132
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "171000"]

Abstract:
Provided herein is a pharmaceutical composition comprising two or more compounds, wherein each compound is independently a phosphodiesterase inhibitor, an adenosine receptor antagonist, a calcium channel blocker, a histamine H 1 -receptor agonist, a histamine H 2 -receptor agonist, a histamine H 3 -receptor antagonist, or a β 2 -adrenoreceptor agonist. Also provided herein is a method of treating, preventing, or ameliorating a cardiovascular disease in a subject, comprising administering to the subject in need thereof two or more compounds, wherein each compound is independently a phosphodiesterase inhibitor, an adenosine receptor antagonist, a calcium channel blocker, a histamine H 1 -receptor agonist, a histamine H 2 -receptor agonist, a histamine H 3 -receptor antagonist, or a β 2 -adrenoreceptor agonist.

Claim (Index 23):
The method of  claim 22 , wherein the cardiovascular disease is bradycardia, symptomatic sinus bradycardia, ventricular bradycardia, atrial bradycardia, cardiac arrhythmia, abnormal heart rhythm, heart block, atrioventricular block, heart failure, sinus arrest, or sinus exit block.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 93.0
- Lexical Diversity: 2.72549
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13438105', '16320949', '11283928', '14771097', '12437766']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7858997944993723
- 35 USC 102 Novelty (BERT): 0.5262668936239603
- Combined Prediction Score: 0.7599365044118311
- Mean Citation Score: 239.491704
- Max Citation Score: 246.69194
- Similarity Product: 114.87543039630532

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test